Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$72.47
+1.7%
$66.93
$54.11
$89.98
$27.49B1.455.47 million shs8.57 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$85.21
-1.3%
$84.85
$72.76
$106.60
$7.22B0.211.00 million shs1.20 million shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$79.92
-0.1%
$75.87
$61.94
$89.29
$9.11B0.821.29 million shs2.08 million shs
McKesson Corporation stock logo
MCK
McKesson
$750.23
-3.8%
$790.35
$637.00
$999.00
$91.30B0.311.07 million shs2.48 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
+1.74%-3.69%+8.24%+8.24%-10.54%
HealthEquity, Inc. stock logo
HQY
HealthEquity
-1.30%-4.22%+0.66%+5.25%-16.46%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
-0.06%-0.37%+9.60%+10.63%+12.36%
McKesson Corporation stock logo
MCK
McKesson
-3.69%-4.85%-1.61%-15.54%+2.87%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$72.47
+1.7%
$66.93
$54.11
$89.98
$27.49B1.455.47 million shs8.57 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$85.21
-1.3%
$84.85
$72.76
$106.60
$7.22B0.211.00 million shs1.20 million shs
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$79.92
-0.1%
$75.87
$61.94
$89.29
$9.11B0.821.29 million shs2.08 million shs
McKesson Corporation stock logo
MCK
McKesson
$750.23
-3.8%
$790.35
$637.00
$999.00
$91.30B0.311.07 million shs2.48 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
+1.74%-3.69%+8.24%+8.24%-10.54%
HealthEquity, Inc. stock logo
HQY
HealthEquity
-1.30%-4.22%+0.66%+5.25%-16.46%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
-0.06%-0.37%+9.60%+10.63%+12.36%
McKesson Corporation stock logo
MCK
McKesson
-3.69%-4.85%-1.61%-15.54%+2.87%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
2.92
Moderate Buy$84.8317.06% Upside
HealthEquity, Inc. stock logo
HQY
HealthEquity
2.86
Moderate Buy$110.5729.76% Upside
Henry Schein, Inc. stock logo
HSIC
Henry Schein
2.43
Hold$87.859.92% Upside
McKesson Corporation stock logo
MCK
McKesson
2.82
Moderate Buy$960.5328.03% Upside

Current Analyst Ratings Breakdown

Latest MCK, DXCM, HQY, and HSIC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/15/2026
DexCom, Inc. stock logo
DXCM
DexCom
Reiterated RatingOverweight$75.00 ➝ $88.00
6/11/2026
Henry Schein, Inc. stock logo
HSIC
Henry Schein
UpgradeNeutralBuy$100.00
6/10/2026
DexCom, Inc. stock logo
DXCM
DexCom
Set Price Target$95.00
6/10/2026
DexCom, Inc. stock logo
DXCM
DexCom
Reiterated RatingBuy$75.00 ➝ $95.00
6/10/2026
McKesson Corporation stock logo
MCK
McKesson
Lower Price TargetOverweight$1,050.00 ➝ $925.00
6/9/2026
DexCom, Inc. stock logo
DXCM
DexCom
Set Price TargetOutperform$75.00 ➝ $85.00
6/8/2026
DexCom, Inc. stock logo
DXCM
DexCom
Reiterated RatingStrong-Buy$91.00
6/5/2026
HealthEquity, Inc. stock logo
HQY
HealthEquity
UpgradeHold (C)Hold (C+)
6/5/2026
DexCom, Inc. stock logo
DXCM
DexCom
Set Price TargetBuy$85.00 ➝ $90.00
6/3/2026
HealthEquity, Inc. stock logo
HQY
HealthEquity
Boost Price TargetOutperform$100.00 ➝ $108.00
6/1/2026
DexCom, Inc. stock logo
DXCM
DexCom
Reiterated RatingHold (C-)
(Data available from 6/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B6.00$2.82 per share25.73$7.04 per share10.29
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.31B5.42$5.21 per share16.36$24.49 per share3.48
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$13.18B0.69$7.77 per share10.28$33.12 per share2.41
McKesson Corporation stock logo
MCK
McKesson
$403.43B0.22$43.85 per share17.11($14.51) per share-51.70
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.3430.9723.841.1119.31%33.33%13.19%7/29/2026 (Estimated)
HealthEquity, Inc. stock logo
HQY
HealthEquity
$215.20M$2.6731.9118.731.4517.25%14.75%9.22%9/1/2026 (Estimated)
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$398M$3.3124.1513.731.542.95%15.44%5.53%8/4/2026 (Estimated)
McKesson Corporation stock logo
MCK
McKesson
$4.76B$38.4719.5015.021.281.18%-345.35%5.85%8/5/2026 (Estimated)

Latest MCK, DXCM, HQY, and HSIC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/28/2026Q1 2027
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.11$1.24+$0.13$0.82$352.02 million$354.64 million
5/7/2026Q4 2026
McKesson Corporation stock logo
MCK
McKesson
$11.56$11.69+$0.13$13.71$101.35 billion$96.30 billion
5/5/2026Q1 2026
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$1.20$1.32+$0.12$0.92$3.34 billion$3.37 billion
4/30/2026Q1 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.47$0.56+$0.09$0.51$1.17 billion$1.19 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
N/AN/AN/AN/AN/A
Henry Schein, Inc. stock logo
HSIC
Henry Schein
N/AN/AN/AN/AN/A
McKesson Corporation stock logo
MCK
McKesson
$3.280.44%+13.68%8.53%17 Years

Latest MCK, DXCM, HQY, and HSIC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/21/2026
McKesson Corporation stock logo
MCK
McKesson
quarterly$0.820.45%6/1/20266/1/20267/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.42
1.95
1.64
HealthEquity, Inc. stock logo
HQY
HealthEquity
0.46
3.44
3.44
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.59
1.36
0.75
McKesson Corporation stock logo
MCK
McKesson
N/A
0.85
0.49

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
HealthEquity, Inc. stock logo
HQY
HealthEquity
99.55%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
96.62%
McKesson Corporation stock logo
MCK
McKesson
85.07%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
HealthEquity, Inc. stock logo
HQY
HealthEquity
1.60%
Henry Schein, Inc. stock logo
HSIC
Henry Schein
0.89%
McKesson Corporation stock logo
MCK
McKesson
0.08%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000385.87 million384.79 millionOptionable
HealthEquity, Inc. stock logo
HQY
HealthEquity
2,81483.60 million82.26 millionOptionable
Henry Schein, Inc. stock logo
HSIC
Henry Schein
25,000113.92 million112.90 millionOptionable
McKesson Corporation stock logo
MCK
McKesson
43,000117.08 million116.98 millionOptionable

Recent News About These Companies

McKesson (MCK) Stock Sinks As Market Gains: Here's Why
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
DexCom stock logo

DexCom NASDAQ:DXCM

$72.47 +1.24 (+1.74%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$73.40 +0.93 (+1.29%)
As of 06/18/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

HealthEquity stock logo

HealthEquity NASDAQ:HQY

$85.21 -1.12 (-1.30%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$82.50 -2.71 (-3.17%)
As of 06/18/2026 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Henry Schein stock logo

Henry Schein NASDAQ:HSIC

$79.92 -0.05 (-0.06%)
Closing price 06/18/2026 04:00 PM Eastern
Extended Trading
$79.50 -0.42 (-0.52%)
As of 06/18/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

McKesson stock logo

McKesson NYSE:MCK

$750.23 -29.57 (-3.79%)
Closing price 06/18/2026 03:59 PM Eastern
Extended Trading
$762.50 +12.27 (+1.64%)
As of 06/18/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.